Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.
Improving prostate cancer survival, a life-extending app, yoga and our tribute to the remarkable Professor Patrick Johnston. Here’s our weekly news report.
We take a look at results from the STAMPEDE clinical trial, which is researching how to improve treatment for men with prostate cancer.
Category: Science blog June 15, 2016
From immunotherapy to targeted cancer treatment, here’s our round up of the big news from the annual ASCO conference.
Here’s the week’s cancer news.
We take a look back at the excitement from – and add a few important caveats to – the research from this year’s big US cancer conference.
This morning’s headlines about vitamin B3 and skin cancer were a little over the top. Here are our thoughts on the research behind the story
In the light of continued media attention, we explain the science behind two exciting new types of immunotherapy drug, called PD-1 and PD-L1 blockers.
Category: Science blog June 7, 2013In our third instalment from the ASCO cancer conference, Debbie Coates writes about a major theme of modern cancer researc...
Category: Science blog June 5, 2013In our second report from this year’s ASCO conference, Trevor Bott writes about a session he attended on the need for cl...